medigraphic.com
SPANISH

Revista Cubana de Medicina General Integral

ISSN 1561-3038 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 3

<< Back Next >>

Rev Cubana Med Gen Integr 2021; 37 (3)

Mixed testicular seminoma

Navarro BAL, Pena ORA, Sánchez SS
Full text How to cite this article

Language: Spanish
References: 13
Page: 1-12
PDF size: 628.62 Kb.


Key words:

seminoma, testicular neoplasm, germ cells.

ABSTRACT

Introduction: Testicular cancer is a rare neoplasm, despite being the most frequent solid tumor in men aged 15-35 years.
Objective: To describe the case of a patient who received attention at the General Hospital of Cienfuegos.
Clinical case: This is the case of a 21-year-old man without risk factors who presents with a scrotal mass, gynecomastia and adenopathies. The complementary texts showed a classic seminoma with anaplastic areas and notable spread, which allowed to classify it as a stage-III neoplasm.
Conclusions: Mortality from testicular cancer is largely preventable. The physical examination is the cornerstone of early diagnosis. It is essential to bear in mind its diagnostic possibility, particularly in young adults. Despite the decrease in mortality from this disease, late diagnosis or in advanced stages, as in this case, hides prognosis.


REFERENCES

  1. Khan O, Protheroe A. Testis cáncer. Postgrad Med J. 2007 [acceso: 21/03/2019];83:624-32. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600126/

  2. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. European Urology. 2016 [acceso: 21/03/2019];70(1):93-105. Disponible en: Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0302283816002062?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0302283816002062%3Fshowall%3Dtrue&referrer=

  3. Saltzman AF, Cost NG. Adolescent and Young Adult Testicular Germ Cell Tumors: Special Considerations. Advances in Urology. 2018 [acceso: 21/03/2019];23(7):51-76. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832033/

  4. Grantham EC, Caldwell BT, Cost NG. Current urologic care for testicular germ cell tumors in pediatric and adolescent patients. Urologic Oncology: Seminars and Original Investigations. 2016 [acceso: 21/03/2019];34(2):65-75. Disponible en: Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S1078143915002963?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1078143915002963%3Fshowall%3Dtrue&referrer=

  5. Tourne M, Radulescu C, Allory Y. Tumeurs germinales du testicule: caractéristiques histopathologiques et moléculaires. Bulletin du Cancer. 2019 [acceso: 21/03/2019];106 (4):328-41. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0007455119301213?via%3Dihub

  6. Drevinskaite M, Patasius A, Kincius M, Jievaltas M, Smailyte G. A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania. Medicina. 2019 [acceso: 21/10/2019];55:552. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780107/pdf/medicina-55-00552.pdf

  7. Boccellino M. Testicular cancer from diagnosis to epigenetic factors. Oncotarget. 2017[acceso: 21/03/2019];8(61):104654-104663. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732834/#

  8. Siddiqui BA, Zhang M, Pisters LL, Tu SM. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Transl Androl Urol. 2020 [acceso: 21/11/2020];9(Suppl 1):S56-S65. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995840/

  9. Stokes W. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database Analysis. Journal of Pediatric Urology 2017; 13(4):386.e1-386.e7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28153774/

  10. Domes Ramón R, Vázquez Mora Y, Abreu Figueredo N, Sosa Rivera M. Valor diagnóstico del ultrasonido en las afecciones testiculares en el Hospital Provincial Docente "Dr. Antonio Luaces Iraola". MediCiego. 2012 [acceso: 21/03/2019];18(2). Disponible en: Disponible en: http://www.revmediciego.sld.cu/index.php/mediciego/article/view/322

  11. Aydin AM, Zemp, Cheriyan SK, Sexton WJ, Johnstone PAS. Contemporary management of early stage testicular seminoma. Transl Androl Urol. 2020 [acceso: 21/11/2020];9(Suppl 1):S36-S44. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995845/pdf/tau-09-S1-S36.pdf

  12. Anderson RE, Hanson HA, Patel DP, Johnstone E, Aston KI, Carrell DT, et al. Cancer risk in first- and second-degree relatives of men with poor semen quality. Fertil Steril. 2016 [acceso: 21/03/2019];106(3):731-8. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617641/pdf/nihms881252.pdf

  13. Pozza C. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study. Human Reproduction 2019 [acceso: 21/03/2019];34(8):1389-403. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688875/




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Med Gen Integr. 2021;37